Close Menu

NEW YORK (GenomeWeb) – Researchers have uncovered a transcriptional signature that is associated with relapse among leukemia patients who have undergone stem cell transplants.

Allogenic hematopoietic celltransplants (allo-HCTs) are a common treatment for leukemia, and while they can lead to a cure, relapses are still frequent among treated patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
01
Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
02
Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.